FDA Approves New Alternative Standard for MQSA Reporting
On October 29, 2024, the FDA approved Alternative Standard #25 allowing the provider an assessment of “Incomplete: Need additional imaging evaluation” for the follow-up report issued within 30 calendar days of an initial report that received an assessment of “Incomplete: Need prior mammograms for comparison”.